Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective, Multicenter, Single-Group Target Value Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPeking University Third Hospital

About this trial

This study aims to evaluate the sensitivity and specificity of a multi-sensor wireless pressure microcatheter for the diagnosis of CMD in patients with ANOCA/INOCA, using quantitative myocardial perfusion imaging of cardiac magnetic resonance (CMR) as a reference.

Eligibility criteria

Qualifiers

Age ≥ 18 years, gender not limited;

Symptoms of angina pectoris, or objective evidence of myocardial ischemia (e.g., electrocardiogram, myocardial injury markers, etc.);

Visual assessment of coronary angiography shows diameter stenosis < 50% and FFR > 0.8 (or cRR > 0.89);

Microvascular function assessment is planned;

Disqualifiers

Acute myocardial infarction, PCI, CABG, or valvular surgery following angiography within the past 30 days;

Severe valvular disease requiring surgical or interventional treatment;

Chest pain with known non-ischemic causes (e.g., pericarditis, pulmonary hypertension, esophageal spasm);

Contraindications to CMR (e.g., certain types of pacemakers or defibrillators, severe claustrophobia);

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed